John Valliant - Chief Executive Officer, Fusion Pharmaceuticals Inc

As of April 27, 2022


What is John Valliant's Net Worth?

The current estimated net worth of Fusion Pharmaceuticals Inc's Chief Executive Officer, John Valliant, is estimated to be about $3.37M . John Valliant owns about 318,147 units of Fusion Pharmaceuticals Inc common stock. In the last year at Fusion Pharmaceuticals Inc, John Valliant has sold an estimated value of $1.6M worth.

What is John Valliant's Past Insider Trading?

John Valliant's largest sale order was 47,502 units , worth over $383.81K on February 17, 2022. In total, John Valliant has made about 18 transactions over a year of their time at Fusion Pharmaceuticals Inc. John Valliant usually trades in March, with the busiest year in 2022. The most recent transaction was a sale order of 8,694 units , worth over $52.51K on April 27, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is John Valliant's' Mailing Address?

  • Mailing address is Fusion Pharmaceuticals Inc. 270 Longwood Road South Hamilton A6 L8P 0A6 Ontario, Canada

What are Fusion Pharmaceuticals Inc's Past Insider Trades?

Fusion Pharmaceuticals Inc's most recent insider trade came on April 27, 2022 by John Valliant who sold 8,694 units worth $52.51K . In the last 2 years, insiders at Fusion Pharmaceuticals Inc have sold an estimated value of $1.7M and bought an estimated value of $55.63M worth of shares. Insider trading is most common in June, with the busiest year in 2022. The most active traders at the company are John Valliant, Chief Executive Officer,  Steve Gannon, Director,  and Chau Khuong, Director .

Fusion Pharmaceuticals Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1